Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Candace S Johnson

Showing results (71-80 of 105) with videos related to

Pageof 11
Sort By:
Cancers|January 30, 2014
Combined effects of circulating levels of 25-hydroxyvitamin d and Th1 and th2 cytokines on breast cancer estrogen receptor statusSong Yao, Chi-Chen Hong, Susan E McCann, et al.
BMC Genomics|August 2, 2015
MAC: identifying and correcting annotation for multi-nucleotide variationsLei Wei, Lu T Liu, Jacob R Conroy, et al.
Bioinformatics (Oxford, England)|January 19, 2012
IMA: an R package for high-throughput analysis of Illumina's 450K Infinium methylation dataDan Wang, Li Yan, Qiang Hu, et al.
Oncotarget|April 8, 2015
Structural variation discovery in the cancer genome using next generation sequencing: computational solutions and perspectivesBiao Liu, Jeffrey M Conroy, Carl D Morrison, et al.
Molecular Cancer Therapeutics|December 21, 2002
Cisplatin potentiates 1,25-dihydroxyvitamin D3-induced apoptosis in association with increased mitogen-activated protein kinase kinase kinase 1 (MEKK-1) expressionPamela A Hershberger, Terence F McGuire, Wei-Dong Yu, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 17, 2008
Vitamin D receptor expression in normal, premalignant, and malignant human lung tissueRavi J Menezes, Richard T Cheney, Aliya Husain, et al.
Cancer Chemotherapy and Pharmacology|October 27, 2006
Phase I study of weekly DN-101, a new formulation of calcitriol, in patients with cancerTomasz M Beer, Milind M Javle, Christopher W Ryan, et al.
Clinical Pharmacology and Therapeutics|December 24, 2002
Pharmacokinetics of high-dose oral calcitriol: results from a phase 1 trial of calcitriol and paclitaxelJosephia R Muindi, Yibing Peng, Douglas M Potter, et al.
BMC Genomics|December 12, 2012
OSAT: a tool for sample-to-batch allocations in genomics experimentsLi Yan, Changxing Ma, Dan Wang, et al.
Cancer Chemotherapy and Pharmacology|February 5, 2008
In vitro and in vivo evaluation of combined calcitriol and cisplatin in dogs with spontaneously occurring tumorsKenneth M Rassnick, Josephia R Muindi, Candace S Johnson, et al.
Pageof 11

Showing results (71-80 of 105) with videos related to

Sort By:
Pageof 11
Cancers|January 30, 2014
Combined effects of circulating levels of 25-hydroxyvitamin d and Th1 and th2 cytokines on breast cancer estrogen receptor statusSong Yao, Chi-Chen Hong, Susan E McCann, et al.
BMC Genomics|August 2, 2015
MAC: identifying and correcting annotation for multi-nucleotide variationsLei Wei, Lu T Liu, Jacob R Conroy, et al.
Bioinformatics (Oxford, England)|January 19, 2012
IMA: an R package for high-throughput analysis of Illumina's 450K Infinium methylation dataDan Wang, Li Yan, Qiang Hu, et al.
Oncotarget|April 8, 2015
Structural variation discovery in the cancer genome using next generation sequencing: computational solutions and perspectivesBiao Liu, Jeffrey M Conroy, Carl D Morrison, et al.
Molecular Cancer Therapeutics|December 21, 2002
Cisplatin potentiates 1,25-dihydroxyvitamin D3-induced apoptosis in association with increased mitogen-activated protein kinase kinase kinase 1 (MEKK-1) expressionPamela A Hershberger, Terence F McGuire, Wei-Dong Yu, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 17, 2008
Vitamin D receptor expression in normal, premalignant, and malignant human lung tissueRavi J Menezes, Richard T Cheney, Aliya Husain, et al.
Cancer Chemotherapy and Pharmacology|October 27, 2006
Phase I study of weekly DN-101, a new formulation of calcitriol, in patients with cancerTomasz M Beer, Milind M Javle, Christopher W Ryan, et al.
Clinical Pharmacology and Therapeutics|December 24, 2002
Pharmacokinetics of high-dose oral calcitriol: results from a phase 1 trial of calcitriol and paclitaxelJosephia R Muindi, Yibing Peng, Douglas M Potter, et al.
BMC Genomics|December 12, 2012
OSAT: a tool for sample-to-batch allocations in genomics experimentsLi Yan, Changxing Ma, Dan Wang, et al.
Cancer Chemotherapy and Pharmacology|February 5, 2008
In vitro and in vivo evaluation of combined calcitriol and cisplatin in dogs with spontaneously occurring tumorsKenneth M Rassnick, Josephia R Muindi, Candace S Johnson, et al.
Pageof 11